« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1
, Pages
264-265
, January 2010
Atypical presentation of IL-12 receptor β1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents
-
Incubation of PBMCs with IFN-γ, LPS, and IL-12 demonstrates intact IFN-γ receptor signaling and aberrant IL-12 responsiveness in this patient. PBMCs were isolated from the patient and a control subjec
Incubation of PBMCs with IFN-γ, LPS, and IL-12 demonstrates intact IFN-γ receptor signaling and aberrant IL-12 responsiveness in this patient. PBMCs were isolated from the patient and a control subject. A, Cells were stimulated with IFN-γ or LPS alone or the combination. Secreted IL-12p70 was measured by ELISA. B, PBMCs were stimulated with either phytohemagglutinin (PHA) or a combination of PHA and IL-12. Secreted IFN-γ was measured by ELISA.
-
Diminished phosphorylation of STAT4 after IL-12 stimulation in this patient. PBMCs from the patient and a control subject were stimulated for 5 days with phytohemagglutinin + IL-2. After stimulation,Diminished phosphorylation of STAT4 after IL-12 stimulation in this patient. PBMCs from the patient and a control subject were stimulated for 5 days with phytohemagglutinin + IL-2. After stimulation, 10 ng/mL IL-12 was added for 20 minutes, and cells were fixed, permeabilized, and stained with anti-pSTAT4 antibody (BD Biosciences, San Jose, Calif). Unstimulated cells served as a control. The histogram for pSTAT4 staining in the IL-12–stimulated lymphocytes is shown in comparison with the unstimulated control. The mean fluorescence intensity (MFI) for pSTAT4 is shown for each sample.
Disclosure of potential conflict of interest: C. M. Seroogy and D. A. Gruenberg have received research support from the National Institutes of Health, the American Academy of Allergy, Asthma & Immunology, and Midwest Athletes Against Childhood Cancer. T. R. Torgerson is on a scientific advisory board for Baxter Healthcare and has received research support from CSL Behring and Grifols. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01324-4
doi: 10.1016/j.jaci.2009.07.061
© 2010 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1
, Pages
264-265
, January 2010
